|Abbott Laboratories of Abbott Park, Ill.||Triclip||Transcatheter tricuspid valve repair system||Nonsurgical treatment for people with tricuspid regurgitation||Received the CE mark|
|Cipla Ltd., of Mumbai||Albuterol inhaler||Generic of Proventil HFA (albuterol sulfate) metered dose inhaler, 90 mcg/Inhalation||Treatment or prevention of bronchospasm in patients four years of age and older||Received approval from the U.S. FDA|
|Diacarta Inc., of Richmond, Calif.||Quantivirus PCR diagnostic test||Real-time quantitative reverse transcriptase PCR assay for use on Applied Biosystems 7500 and Quantstudio 5; produces results within 2 hours following RNA extraction||Detects the N, Orf1ab and E genes of SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal swabs and sputum samples||Received emergency use authorization from the U.S. FDA|
|DNAe Group Holdings Ltd., of London||Lidia-SEQ||Direct-from-specimen platform that performs genomic analysis on a microchip||Tests for bloodstream infections and antimicrobial resistance to identify infections that can lead to sepsis||Received breakthrough device designation from the U.S. FDA|
|Vapotherm Inc., of Exeter, N.H.||Oxygen Assist Module||Algorithm-based module for use with most versions of Vapotherm's Precision Flow systems||Maintains oxygen saturation in target range||Received breakthrough device designation from the U.S. FDA|
|Silk Medical Aesthetics Inc., of Boston||Injectable form of Evolved By Nature's Activated Silk||Silk-based dermal filler||For use in the nasolabial fold of the face for volume correction||Received investigational device exemption from the U.S. FDA to initiate a human clinical trial|
For more information about individual companies and/or products, see Cortellis.